Neurocrine Biosciences (NBIX) – Options
-
Neurocrine (NBIX) volatility elevated into FDA approval of INGREZZA capsules
-
Neurocrine Biosciences (NBIX) September volatility at 108 into top-line data
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NBIX Stock Lookup